Abstract
We describe 3 fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis and death after the administration of oxaliplatin as part of the FOLFOX regimen. Due to the widespread use of oxaliplatin in oncology, clinicians should be aware of the risk and severity of oxalipatin-induced interstitial pneumonia. Copyright © 2012 S. Karger AG, Basel.
Author supplied keywords
Cite
CITATION STYLE
APA
Pontes, L. B., Armentano, D. P. D., Soares, A., & Gansl, R. C. (2012). Fatal pneumonitis induced by oxaliplatin: Description of three cases. Case Reports in Oncology, 5(1), 104–109. https://doi.org/10.1159/000337030
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free